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During the last years, a growing number of inherited skin disorders have been recognized to be caused by
abnormal function of desmosomal proteins. In the present study, we describe the ﬁrst female individuals affected
with the ectodermal dysplasia/skin fragility syndrome (MIM604536), a rare autosomal recessive disease due to
mutations in the PKP1 gene encoding plakophilin 1, a critical component of desmosomal plaque. One patient was
shown to carry a homozygous splice site mutation in intron 4. The second patient displayed a homozygous
recurrent mutation affecting the acceptor splice site of intron 1. Both mutations were associated with
intraepidermal separation, widening of intercellular spaces, and abnormal desmosome ultrastructure, and were
found to result in the absence of immunoreactive plakophilin 1 in the epidermis of the affected individuals. These
two cases emphasize the role of molecular genetics in the assessment of congenital blistering in newborns and
illustrate the importance of proper desmosomal activity for normal epidermis development and function.
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Congenital blistering can pose a serious diagnostic chal-
lenge to the pediatric dermatologist (Schachner and Press,
1983). Among blistering genodermatoses, epidermolysis
bullosa a heterogeneous group of inherited skin diseases
ranks first in terms of prevalence (Fine et al, 1999). A
number of additional inherited vesiculobullous disorders,
however, have been recognized to be part of this expanding
spectrum of diseases, including epidermolytic hyperkera-
tosis (MIM113800),1 Kindler syndrome (MIM173650; Kind-
ler, 1954), and ectodermal dysplasia/skin fragility (EDSF)
syndrome (MIM604536; McGrath et al, 1997).
EDSF, an autosomal recessive disorder, manifests with
skin fragility, palmoplantar keratoderma, abnormal hair
growth, and nail dystrophy and, in some but not all cases,
with defective sweating (Whittock et al, 2000). Since its
initial description in 1997, the syndrome has been shown in
four male individuals to result from mutations in the PKP1
gene encoding plakophilin 1 (PKP1), a critical component
of the desmosomal plaque (McGrath et al, 1997, 1999;
Whittock et al, 2000; Hamada et al, 2002).
In the present report, we describe two children initially
suspected of being affected with staphylococcal scalded
skin syndrome and epidermolysis bullosa, and who were
eventually shown to carry homozygous mutations in PKP1
resulting in lack of plakophilin 1 expression and underlying
EDSF. These cases emphasize the complexity of the
differential diagnosis of congenital bullous eruptions in
newborns and illustrate the power of molecular genetic
analysis in the assessment of this group of disorders.
Results
Clinical description Family 1 comprised a 6-mo-old
affected female child who was the offspring of healthy first
cousins of Arab Moslem origin. She had a healthy brother.
She was delivered vaginally after 37 wk of an uneventful
pregnancy. A few hours after birth, superficial blisters were
noticed on several parts of her body, which suggested the
diagnosis of staphylococcal scalded skin syndrome. The
child’s general behavior was normal. She had no fever. She
received parenteral ampicillin and gentamicin without
improvement for 4 d. Cultures obtained from several sites
remained sterile. The child was referred to our outpatient
clinics with a clinical diagnosis of epidermolysis bullosa at
10 d of age. On physical examination, numerous erosions
were evident on the occipital aspect of the scalp (Fig 1a), on
the face in a perioral distribution (Fig 1b), and on the
extensor parts of the limbs. No mucosal lesions or
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palmoplantar involvement were observed and there was
no evidence of abnormal sweating. The child, however,
displayed prominent nail dystrophy and severe hypotricho-
sis (Fig 1a). The remaining hairs were short, coarse, and curly.
Eyebrows and eyelashes were present. Severe pruritus was
reported by the parents and evident during physical
examination. Routine laboratory tests were normal. Echo-
cardiography revealed patent foramen ovale with mild left to
right shunt. Histopathological examination of a skin biopsy
stained with hematoxylin–eosin revealed widened intercel-
lular spaces and suprabasal intraepidermal clefts with
acantholytic cells (Fig 1d). Electron microscopic examina-
tion of a lesional skin biopsy disclosed, mainly in the
spinous layers, a widening of intercellular spaces with a
reduced number of small and often distorted desmosomes,
not attached to tonofilaments. Normal-appearing desmo-
somes were usually not observed. (Fig 1e). Light micro-
scopic examination of plucked hair was unremarkable.
The second patient was a 3-y-old female child belonging
to a consanguineous family of Arab Moslem origin. Her
parents were unaware of any familial relationship to family 1.
The child presented clinical features strikingly similar to
those displayed by the first patient. Two brothers with
congenital skin generalized erythema and blistering died at
the age of 2 wk of sepsis. She was born after an uneventful
pregnancy. Soon after birth, general erythroderma and skin
blisters were observed. Nail dystrophy was noted (Fig 1c).
She was discharged with a diagnosis of epidermolysis
bullosa. Her disease course was initially complicated by
recurrent episodes of pneumonia and sepsis as well as
marked failure to thrive. During the first year of life, the
erythroderma receded and skin blisters occurred less
frequently. Itching became prominent and palmoplantar
keratoderma progressively developed. On physical exam-
ination, she displayed skin blisters and erosions over the
feet (Fig 1c), the limbs, and around the mouth; sparse,
coarse scalp hair; palmoplantar hyperkeratosis; and yellow-
ish and thickened nails (Fig 1c). Routine blood tests were
normal. Chest computed tomography disclosed a right
aortic arch. Examination of a skin biopsy revealed supra-
basal intraepidermal separation with many epidermal cells
with increased eosinophilic cytoplasm as in dyskeratotic
keratinocytes. Electron microscopic examination of a skin
biopsy revealed intraepidermal skin separation and acan-
tholysis (not shown).
Mutational analysis Since many of the clinical findings
displayed by both patients had previously been reported in
association with EDSF (McGrath et al, 1997), we sequenced
the entire coding region of the PKP1 gene including intron–
exon boundaries. The affected child of family 1 was shown
to carry a homozygous A ! G transition in intron 4 at
nucleotide position 847-2 (accession number NM_000299)
(Fig 2a). The mutation, termed 847-2A4G, affects the
consensus acceptor splice site of intron 4 and is expected
to lead to aberrant splicing. The mutation was shown to be
carried in a heterozygous state by both parents and to be
absent in the patient’s unaffected brother. The family 2
patient displayed a homozygous G ! A transition at nucle-
otide position 203-1 (Fig 2a). The 203-1G4A mutation
modifies the consensus acceptor splice site of intron 1 and
is predicted to result in abnormal splicing too. The mutation
was shown to be carried in a heterozygous state by both
parents. This mutation has previously been described in an
EDSF patient of Anglo-Saxon origin (McGrath et al, 1999)
and represents the first recurrent mutation in PKP1
described to date.
847-2A4G generates a novel restriction site for FauI
while 203-1G4A generates a novel recognition site for
DdeI. Segregation of the mutation in both families was
confirmed by PCR-RFLP (Fig 2b, c). The 847-2A4G
mutation was absent from a panel of 100 control chromo-
somes.
Consequences of splice site mutations in PKP1 In silico
simulation using the Splice Site Prediction by Neural
Figure 1
Clinical features of ESDF. (a) Sparse, short, and coarse hair on the scalp with numerous skin superficial erosions (family 1 patient). (b) Perioral
superficial erosions (family 1 patient). (c) Toenail plate thickening and yellowish discoloration as well as superficial erosions over foot dorsum (family
2 patient). (d) Suprabasal and intraepidermal clefts with a few acantholytic keratinocytes in a skin biopsy obtained from the family 1 patient. The
adjacent spinous zone demonstrates widened intercellular spaces (hematoxylin–eosin, original scale bar¼100mm). (e) Electron micrograph of a skin
biopsy obtained from the family 1 patient showing widened intercellular spaces between keratinocytes. Keratinocytes show perinuclear retraction of
tonofilaments (scale bar¼ 2mm). Few rudimentary desmosomes without attached tonofilaments are seen between keratinocytes (insert, scale
bar¼ 0.3mm).
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Network software (http://www.fruitfly.org/seq_tools/splice.
html) revealed a number of possible consequences of the
847-2A4G mutation, including exon skipping, integration
of intron 4 within the mature mRNA, and activation of a
number of potential cryptic splicing sites. In each case, the
resulting mRNA is predicted to carry a premature termina-
tion codon, which may either lead to the synthesis of a
truncated protein or to nonsense-mediated mRNA decay
(Frischmeyer and Dietz, 1999). In order to explore these
different possibilities, we extracted RNA from a skin biopsy
obtained from non-lesional skin of the family 1 patient and
amplified a fragment of the cDNA encompassing exon 5 as
described in Materials and Methods using primers specific
for PKP1 and b-actin. Patient PKP1 cDNA was less
abundant and of a slightly higher size as compared with
control PKP1 cDNA (Fig 2d). Sequencing of the patient RT-
PCR product revealed the presence of an additional 26 bp
within the mutant cDNA due to the activation of a cryptic
acceptor splice site located at nucleotide position 847-28
within intron 4. As a consequence, a premature termination
codon is introduced 169 bases downstream to the normal
intron 4 acceptor splice site. RNA was not available from the
family 2 patient. A previous study, however, showed that
this mutation is likely to result in premature termination of
protein translation too (McGrath et al, 1999).
To correlate these results at the protein level, we stained
frozen biopsy sections of both patients with a monoclonal
antibody directed against PKP1. No immunoreactive PKP1
protein could be detected by immunofluorescence in the
skin of the two EDSF patients as compared with normal skin
(Fig 2e). Thus, the 847-2A4G and 203-1G4A mutations
result in plakophilin 1 deficiency.
Figure 2
Molecular analysis. (a) Mutation identification. Sequence analysis reveals a homozygous splice site mutation (847-2A4G) in intron 4 in the affected
individual of family 1, and a homozygous splice site mutation (203-1G4A) in intron 1 in the affected individual of family 2 (arrow, upper panels). The
wild-type sequences are given for comparison (lower panels). (b) Verification of 847-2A4G. 847-2A4G creates a novel recognition site for FauI
endonuclease. A 527 bp fragment encompassing exon 5 was amplified as previously described (Whittock et al, 2000) and digested with FauI. The
affected patient displays a 367 bp fragment that is not shown by her unaffected brother, but is carried in a heterozygous state by both her parents.
(c) Verification of 203-1G4A. 203-1G4A creates a novel recognition site for DdeI endonuclease. A 374 bp fragment encompassing exon 2 was
amplified as previously described (Whittock et al, 2000) and digested with DdeI. The affected patient displays a novel 237 bp fragment while her
heterozygous parents carried both the 237 bp fragment and a wild-type 298 bp fragment. Additional fragments of length 22 bp, 54 bp, and 61 bp are
not visible. (d) Effect of 847-2A4G on PKP1 RNA levels. Total RNA was extracted from skin biopsies obtained from family 1 patient (P) or from an
unrelated control individual (C) and amplified using primer pairs specific for PKP1 or b-actin. Patient-derived PKP1 cDNA was less abundant than
control-derived PKP1 cDNA. (e) Immunofluorescence study. Staining of skin biopsies demonstrates the absence of immunoreactive PKP1 protein in
the skin of the family 1 patient (/) as opposed to normal membranal staining in the epidermis of a healthy unrelated control individual (þ /þ ). (f)
Spectrum of mutations in PKP1. Mutations are indicated along a schematic representation of the plakophilin 1 molecule. Armadillo repeats are
represented in orange, and the head domain is depicted in blue.
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Discussion
A total of four sporadic cases of EDSF have been reported
to date (McGrath et al, 1997, 1999; Whittock et al, 2000;
Hamada et al, 2002). All patients demonstrated skin fragility,
nail dystrophy, palmoplantar keratoderma, and alopecia,
and all were shown to carry mutations predicted to result in
premature termination codons (Fig 2f). The present cases,
the first female patients with EDSF ever described, perfectly
fit the general paradigm of EDSF except for the absence of
palmoplantar keratoderma and skin thickening in the family
1 patient. Since this child is an 8-mo-old only, we cannot
exclude the possibility that keratoderma will develop in the
future, especially once the child becomes more active.
Thus, given the clinical similarities between the present
cases and the previously described Japanese and Eur-
opean patients, it seems that neither sex nor ethnic origin
significantly influence the phenotypic expression of muta-
tions in the PKP1 gene. 203-1G4A is the first reported
recurrent mutation in PKP1. The 203-1 nucleotide position is
likely to represent a mutational hot spot, since 203-1G4A
was initially described in a compound heterozygous state in
a child of Anglo-Saxon descent whereas the present case is
of Arab Moslem origin.
The PKP1 gene codes for two alternatively spliced PKP1
variants: the short variant, PKP1a, is a major component of
the desmosomal plaque in all stratified epithelia, while the
long variant, PKP1b, is exclusively found in the nucleus
where it may play a role in signal transduction (Schmidt
et al, 1997). Keratin intermediate filaments binding to desmo-
somal plaque, at least in lower suprabasal epidermal cells,
is critically dependent on normal PKP1 function (McGrath
et al, 1997). Recent data suggest that the N-terminal
domain of PKP1 stabilizes lateral interactions between
desmoplakin molecules, which in turn bind to keratin
molecules (Kowalczyk et al, 1999). This may account for
recent results demonstrating that PKP1 stabilizes a number
of critical components of desmosomal plaque, plays a role
in the transition of desmosomes from a calcium-dependent
to a calcium-independent state, and regulates keratinocyte
motility (South et al, 2003). The absence of PKP1 expres-
sion in EDSF, as shown in our two patients, may thus
explain abnormal desmosome assembly and aberrant cell–
cell adhesion within the epidermis leading to epidermal
acantholysis (Fig 1e). Normal desmosomal function also
seems to be required during hair morphogenesis since
mutations in two desmosomal proteins, desmoglein 4 (Kljuic
et al, 2003) and corneodesmosin (Levy-Nissenbaum et al,
2003), underlie recessive and dominant hypotrichosis
simplex. Thus, alopecia in EDSF may result from impaired
desmosomal function as well.
Severe itching was noticed in our patients and pruritus
was also reported in a previous report of an EDSF patient
(Whitock et al, 2000). Pruritus is strongly associated with
disruption of epidermal barrier integrity. Although no clear
pathomechanistic relationship has been established be-
tween desmosome dysfunction and pruritus, it is of note
that engineered mice, lacking desmocollin 1, a critical com-
ponent of desmosomal plaque, display a phenotype with
striking similarities to EDSF, including skin fragility with
evidence for acantholysis, hair abnormalities, and epidermal
thickening associated with significant loss of barrier activity
and chronic dermatitis (Chidgey et al, 2001). Thus, the effect
of PKP1 deficiency on epidermal barrier function deserves
further scrutiny.
EDSF is one of a number of desmosomal genoderma-
toses described during recent years and which include
dominantly (e.g., striate palmoplantar keratoderma) as well
as recessively (e.g., Naxos disease) inherited disorders
(reviewed in McMillan and Shimizu, 2001). Although
diseases caused by recessive mutations in desmosomal
proteins share numerous characteristics such as kerato-
derma and alopecia (McGrath et al, 1997; McKoy et al,
2000; Norgett et al, 2000), EDSF is the only one including
skin blistering/fragility as a prominent feature. In contrast,
cardiac manifestations are a hallmark of recessive muta-
tions in genes coding for at least two other desmosomal
proteins, desmoplakin and plakoglobin (McKoy et al, 2000;
Norgett et al, 2000; Whittock et al, 2002). Although a patent
foramen ovale and a right aortic arch were noticed in our
patients, no major cardiovascular abnormality was identi-
fied, probably reflecting the tissue-specific pattern of
expression of PKP1 (Moll et al, 1997).
In summary, we have identified a novel and a recurrent
mutation in PKP1 underlying EDSF in two female patients.
These two cases illustrate the etiological diversity asso-
ciated with congenital skin blistering, emphasize the role
of molecular genetics in the assessment of skin fragility
syndromes in children, and demonstrate once again the
importance of proper desmosomal activity for epidermis
normal development and function.
Materials and Methods
Patients and biological materials All participants or their legal
guardian provided written and informed consent according to a
protocol previously approved by the local Helsinki Committee and
by the Committee for Genetic Studies of the Israeli Ministry of
Health. Blood samples were drawn from all family members and
DNA was extracted according to standard procedures. Skin
biopsies were obtained from the patients and processed for
histopathology and electron microscopy as previously described
(Bergman et al, 1997).
Mutation analysis Genomic DNA of affected individuals was
PCR-amplified using PKP1 specific primer pairs (Whittock et al,
2000) with Taq polymerase and Q solution (Qiagen, Valencia,
California). Cycling conditions were 951C 5 min followed by 35
cycles at 951C 30 s, 571C–601C 45 s, 721C 90 s, and a final
extension step at 721C for 7 min. Resulting amplicons were gel-
purified (QIAquick gel extraction kit, Qiagen) and subjected to
bidirectional DNA sequencing using the BigDye terminator system
on an ABI Prism 3100 sequencer (PE Applied Biosystems, Foster
City, California).
Reverse-transcription polymerase chain reaction Total RNA
was extracted from a snap-frozen skin biopsy obtained from non-
lesional skin using the RNeasy extraction kit (Qiagen) and amplified
using the TITAN One Tube RT-PCR kit (Roche Molecular
Biochemicals, Mannheim, Germany) and intron-crossing primer
pairs specific for PKP1 located in exons 3 and 7, respectively
(forward 50-GCGCTTCAGCTCCTACAGCC-30 and reverse 50-
CGCTACACAGTTCTGGACATAG-30). PCR conditions were: 30
min at 501C; 941C for 2 min; 941C for 30 s, 601C for 30 s and
681C for 90 s, for a total of 10 cycles; 941C for 30 s, 601C for 30 s
and 681C for 90 s þ five additional seconds at each cycle, for a
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total of 25 cycles; a final extension step at 681C for 7 min. The
resulting amplicons were then amplified using Taq polymerase, Q
solution (Qiagen), and nested primers located in exons 3 and 7,
respectively (forward 50-CGGCGCAGGCAGCGACATCTG-30 and
reverse 50-CATGAGGGAATCAATGAGC-30; expected size 889 bp).
Cycling conditions were 951C 5 min followed by 35 cycles at 951C
30 s, 601C 45 s, 721C 90 s, and a final extension step at 721C for
7 min. The PCR products were gel-purified (QIAquick gel extraction
kit, Qiagen) and subjected to bidirectional DNA sequencing using
the BigDye terminator system on an ABI Prism 377 sequencer (PE
Applied Biosystems). As a control, we amplified as described
above total RNA with primers specific for b-actin (forward 50-
CCAAGGCCAACCGCGAGAAGATGAC-30 and reverse 50-AGGG-
TACATGGTGGTGCCGCCAGAC-30; expected size 587 bp).
Immunoﬂuorescence studies Skin biopsies were snap-frozen in
liquid nitrogen, and 6 mm cryostat sections were mounted on
polylysine-coated slides and air-dried. Slides were incubated with
a primary mouse anti-plakophilin 1 monoclonal antibody (clone
10B2; Zymed, San Francisco, California) for 1 h at room tempera-
ture and with a secondary FITC-conjugated goat anti-mouse IgG
antibody (Zymed) for 30 min. The sections were then examined
under an Axioscop2 upright microscope (Zeiss, Thornwood, New
York) and images were processed using Image Proþ (Media
Cybernetics, Silverspring, Maryland).
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